Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/89170
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Optometry-
dc.creatorZhou, ZG-
dc.creatorJiang, DX-
dc.creatorXie, SM-
dc.creatorZhang, J-
dc.creatorZheng, F-
dc.creatorPeng, H-
dc.creatorChen, X-
dc.creatorLiu, JY-
dc.creatorZhang, L-
dc.date.accessioned2021-02-04T02:39:58Z-
dc.date.available2021-02-04T02:39:58Z-
dc.identifier.urihttp://hdl.handle.net/10397/89170-
dc.language.isoenen_US
dc.publisherNature Publishing Groupen_US
dc.rights© The Author(s) 2020en_US
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.rightsThe following publication Zhou, Z. -., Jiang, D. -., Xie, S. -., Zhang, J., Zheng, F., Peng, H., . . . Zhang, L. (2020). Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19. Signal Transduction and Targeted Therapy, 5(1), 276, 1-3 is available at https://dx.doi.org/10.1038/s41392-020-00407-0en_US
dc.titleLow-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19en_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1-
dc.identifier.epage3-
dc.identifier.volume5-
dc.identifier.issue1-
dc.identifier.doi10.1038/s41392-020-00407-0-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationSignal transduction and targeted therapy, 2020, v. 5, no. 1, 276, p. 1-3-
dcterms.isPartOfSignal transduction and targeted therapy-
dcterms.issued2020-
dc.identifier.isiWOS:000595956700004-
dc.identifier.scopus2-s2.0-85096521011-
dc.identifier.pmid33235253-
dc.identifier.eissn2059-3635-
dc.identifier.artn276-
dc.description.validate202101 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
s41392-020-00407-0.pdf1.2 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

56
Last Week
0
Last month
Citations as of May 12, 2024

Downloads

13
Citations as of May 12, 2024

SCOPUSTM   
Citations

6
Citations as of May 16, 2024

WEB OF SCIENCETM
Citations

4
Citations as of May 16, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.